Reimbursement Policies for Investigational Device Exemptions (IDEs) Industry View - Mitchell Sugarman, MBA

↳ This is a section part of Moment: CRT 2015 Technology & Innovation - Session II: Pivotal Study Initiation and Conduct

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Reimbursement Policies for Investigational Device Exemptions (IDEs) Industry View presented by Mitchell Sugarman, MBA at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physicians with an interest in Cardiovascular Innovations 

Session Name: Session II: Pivotal Study Initiation and Conduct

Track: Technology & Innovation

Learning Objectives

  • Updates in the latest Cardiovascular Innovations

Other Components in this Moment

Overview
Reimbursement Policies for Investigational Device Exemptions (IDEs) CMS view - Tamara Syrek Jensen, JD
Reimbursement Policies for Investigational Device Exemptions (IDEs) Industry View - Mitchell Sugarman, MBA
US Clinical Study Challenges, Including IDE Approval (Including Nonclinical Data Requirements) - Aaron V. Kaplan, MD
Clinical Trial Metrics: A Proposal for Improving Medical Device IRB, Contracting and Study Conduct - Chip Hance
FDA Initiatives to Improve the Clinical Study Ecosystem - Owen P. Faris, PhD
Keynote Address: FDACDRH in the Next Decade – A Vision for Change - William H. Maisel, MD
Loading Simple Education